Results News
Aurobindo Pharma: Crisis of confidence
For the past year, investors of Aurobindo Pharmaceuticals had been almost snowed under with negative surprises. While the stock price had been hammered down 40 per cent over the past year, the company failed to inspire confidence, claim analysts. The crisis started last February when the company came under the scrutiny of the the US Food and Drugs Administration (FDA), which resulted in an import
Results Galleries
Results Videos
|
|
